All In MedTech

Company

Angiodynamics

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

ANGO

Nasdaq · ANGIODYNAMICS INC

Public float

$436M

Value of shares held by non-insiders on Nov 30, 2025

Revenue

$320M

Fiscal year ending May 31, 2026

Net income

-$36.7M

Fiscal year ending May 31, 2026

R&D spending

$29.4M

Fiscal year ending May 31, 2026

Cash

$34.0M

As of Aug 31, 2026

Long-term debt

Not reported

Shares outstanding

42.1M

As of Oct 7, 2026

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For Angiodynamics we have 2 shareholders with 5% or more.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

The 8 newest of 34 since 2015.

Search the Clearance Tracker

31 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

19 more trials with a free account

Reports received

436

Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.

Malfunction reports

197

45% of reports

Injury reports

222

51% of reports

Death reports

16

3.7% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2327410
Jan 2423400
Feb 2418610
Mar 2434300
Apr 2412801
May 2410410
Jun 2412510
Jul 2421510
Aug 2413800
Sep 2426200
Oct 24253330
Nov 24161210
Dec 24571010
Jan 2523810
Feb 2522690
Mar 25312720
Apr 2524410
May 25101420
Jun 25171101
Jul 25281700
Aug 2514800
Sep 25332330
Oct 25181720
Nov 25141710
Dec 25251910
Jan 2610720
Feb 2621900
Mar 26153320
Apr 26151330
May 26181900
Jun 26132020
Jul 26162420
Aug 26131921
Sep 26132310
Oct 26241900
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

7 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

292 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.